Quipt Home Medical (QIPT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
6 Jan, 2026Executive summary
Special meeting of shareholders scheduled for March 3, 2026, in Sarasota, FL, to consider a proposed transaction involving 1567208 B.C. LTD and REM Aggregator, LLC.
Record date for notice and voting is January 22, 2026; beneficial ownership determination also set for this date.
Forward-looking statements caution on timing and completion of the transaction, subject to regulatory, court, and shareholder approvals.
Proxy statement and management information circular will be filed and mailed to securityholders; materials will be available on SEC and SEDAR+.
Voting matters and shareholder proposals
Shareholders will vote on the proposed transaction at the special meeting.
Proxy-related materials will be sent directly to non-objecting beneficial owners (NOBO) and delivery to objecting beneficial owners (OBO) will be paid for by the issuer.
Board of directors and corporate governance
Directors and executive officers may be considered participants in the proxy solicitation for the proposed transaction.
Information about directors and officers is available in the annual general meeting proxy statement filed January 24, 2025.
Latest events from Quipt Home Medical
- Q2 and Q3 revenue hit $64M with strong margins, recurring revenue, and diabetes expansion focus.QIPT
Q3 20248 Jul 2026 - Record revenue and recurring growth in 2024 set the stage for renewed organic growth in 2025.QIPT
Q4 20248 Jul 2026 - Record revenue and EBITDA growth fueled by recurring revenue and strategic acquisitions.QIPT
Corporate presentation7 Apr 2026 - Revenue up 32% to $80.996M; acquisition at $3.65/share pending; net loss narrows to $1.053M.QIPT
Q1 20269 Feb 2026 - Shareholders to vote on a $3.65/share acquisition with strong board and major holder support.QIPT
Proxy Filing4 Feb 2026 - Shareholders to receive $3.65 per share in cash upon approval of the acquisition arrangement.QIPT
Proxy Filing4 Feb 2026 - Shareholders to vote on $3.65 per share cash buyout, with board and fairness opinions supporting approval.QIPT
Proxy Filing4 Feb 2026 - Shareholders to vote on all-cash acquisition after key regulatory milestone achieved.QIPT
Proxy Filing26 Jan 2026 - Shareholders to vote on a $3.65 per share all-cash acquisition with a 39.9% premium.QIPT
Proxy Filing13 Jan 2026